Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Cash: 2022-2023

Historic Change in Cash for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to -$7.7 million.

  • Therapeutics' Change in Cash rose 11.00% to -$7.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$9.3 million, marking a year-over-year increase of 97.18%. This contributed to the annual value of -$14.9 million for FY2024, which is 59.85% down from last year.
  • According to the latest figures from Q4 2023, Therapeutics' Change in Cash is -$7.7 million, which was up 75.58% from -$31.6 million recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Change in Cash ranged from a high of $70.4 million in Q1 2023 and a low of -$191.9 million during Q1 2022.
  • Moreover, its 2-year median value for Change in Cash was -$25.2 million (2022), whereas its average is -$42.3 million.
  • Within the past 5 years, the most significant YoY rise in Therapeutics' Change in Cash was 136.67% (2023), while the steepest drop was 68.10% (2023).
  • Therapeutics' Change in Cash (Quarterly) stood at -$8.7 million in 2022, then grew by 11.00% to -$7.7 million in 2023.
  • Its Change in Cash was -$7.7 million in Q4 2023, compared to -$31.6 million in Q3 2023 and -$40.4 million in Q2 2023.